Ubs Group Ag Mustang Bio, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.35 - $0.72 $497 - $1,023
1,421 Added 65.97%
3,575 $1,000
Q4 2022

Feb 08, 2023
BUY
$0.32 - $8.27 $561 - $14,505
1,754 Added 438.5%
2,154 $0
Q3 2022

Nov 10, 2022
BUY
$0.46 - $7.2 $184 - $2,880
400 New
400 $0
Q2 2022

Aug 10, 2022
SELL
$0.58 - $1.13 $4,683 - $9,124
-8,075 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.73 - $1.81 $51,601 - $127,943
-70,687 Reduced 89.75%
8,075 $8,000
Q4 2021

Feb 14, 2022
BUY
$1.66 - $2.64 $124,934 - $198,691
75,262 Added 2150.34%
78,762 $131,000
Q3 2021

Nov 15, 2021
SELL
$2.58 - $3.36 $40,134 - $52,268
-15,556 Reduced 81.63%
3,500 $9,000
Q2 2021

Aug 13, 2021
BUY
$2.7 - $3.81 $21,602 - $30,483
8,001 Added 72.37%
19,056 $63,000
Q1 2021

May 12, 2021
SELL
$3.02 - $5.16 $7,293 - $12,461
-2,415 Reduced 17.93%
11,055 $37,000
Q4 2020

Feb 11, 2021
BUY
$2.66 - $4.18 $32,366 - $50,862
12,168 Added 934.56%
13,470 $51,000
Q3 2020

Nov 12, 2020
SELL
$3.01 - $3.88 $61,692 - $79,524
-20,496 Reduced 94.03%
1,302 $5,000
Q2 2020

Jul 31, 2020
BUY
$2.33 - $4.6 $9,813 - $19,375
4,212 Added 23.95%
21,798 $70,000
Q1 2020

May 01, 2020
SELL
$1.91 - $4.52 $49,772 - $117,786
-26,059 Reduced 59.71%
17,586 $47,000
Q4 2019

Feb 14, 2020
BUY
$2.57 - $4.08 $56,100 - $89,062
21,829 Added 100.06%
43,645 $178,000
Q3 2019

Nov 14, 2019
BUY
$2.74 - $4.65 $42,985 - $72,949
15,688 Added 256.01%
21,816 $71,000
Q2 2019

Aug 14, 2019
BUY
$2.66 - $6.28 $3,990 - $9,420
1,500 Added 32.41%
6,128 $23,000
Q1 2019

May 14, 2019
SELL
$2.95 - $5.61 $3,746 - $7,124
-1,270 Reduced 21.53%
4,628 $16,000
Q4 2018

Feb 14, 2019
SELL
$2.3 - $5.78 $10,715 - $26,929
-4,659 Reduced 44.13%
5,898 $17,000
Q3 2018

Nov 14, 2018
BUY
$5.71 - $7.58 $46,348 - $61,526
8,117 Added 332.66%
10,557 $63,000
Q2 2018

Aug 14, 2018
BUY
$6.68 - $11.0 $8,577 - $14,124
1,284 Added 111.07%
2,440 $17,000
Q1 2018

May 15, 2018
SELL
$10.14 - $12.38 $14,733 - $17,988
-1,453 Reduced 55.69%
1,156 $13,000
Q4 2017

Feb 14, 2018
BUY
$8.75 - $11.99 $22,828 - $31,281
2,609
2,609 $31,000

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0
View Full List

About MUSTANG BIO, INC.

MBIO Quotes by TradingView
  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $23.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email